Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $23.9M | 0.03% |
+248,082
| New | +$23.8M |
|
602
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $23.9M | 0.03% |
349,321
+87,970
| +34% | +$5.75M |
|
603
Interactive Brokers
IBKR
$42.5B
| $23.9M | 0.03% |
+274,516
| New | +$22.8M |
|
604
MongoDB
MDB
$34.7B
| $23.9M | 0.03% |
71,083
-82,680
| -54% | -$24.8M |
|
605
Yum! Brands
YUM
$41.8B
| $23.8M | 0.03% |
148,808
-471,329
| -76% | -$73M |
|
|
PR
606
Permian Resources
PR
$19.9B
| $23.7M | 0.03% |
1,287,306
+934,709
| +265% | +$18.8M |
|
607
CVS Health
CVS
$119B
| $23.7M | 0.03% |
228,956
-962,067
| -81% | -$85.9M |
|
608
Minerva Neurosciences
NERV
$231M
| $23.6M | 0.03% |
4,257,000
-1,600
| -0% | -$8.68K |
|
609
PUT
Delta Air Lines
DAL
$54.2B
| $23.6M | 0.03% |
252,100
+68,100
| +37% | +$5.14M |
|
610
Sutro Biopharma
STRO
$349M
| $23.6M | 0.03% |
711,162
+245,370
| +53% | +$7.65M |
|
611
PUT
Coinbase
COIN
$49.2B
| $23.6M | 0.03% |
161,100
-11,400
| -7% | -$2.06M |
|
612
CALL
Lam Research
LRCX
$393B
| $23.5M | 0.03% |
54,300
+6,000
| +12% | +$1.82M |
|
613
Viridian Therapeutics
VRDN
$2.75B
| $23.5M | 0.03% |
1,279,859
-1,036,098
| -45% | -$16.7M |
|
614
Phillips Edison & Co
PECO
$5.05B
| $23.5M | 0.03% |
563,639
-140,983
| -20% | -$5.63M |
|
615
CALL
IBM
IBM
$222B
| $23.5M | 0.03% |
83,400
+43,500
| +109% | +$11M |
|
|
616
PUT
Applied Materials
AMAT
$391B
| $23.3M | 0.03% |
32,200
-2,000
| -6% | -$923K |
|
617
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
| $23M | 0.03% |
+214,642
| New | +$24.5M |
|
618
General Motors
GM
$77.2B
| $23M | 0.03% |
298,053
-525,558
| -64% | -$41.3M |
|
619
PUT
Goldman Sachs
GS
$303B
| $23M | 0.03% |
22,700
+9,500
| +72% | +$9.26M |
|
620
PUT
Palo Alto Networks
PANW
$292B
| $23M | 0.03% |
67,300
-97,300
| -59% | -$22.3M |
|
621
Meritage Homes
MTH
$4.67B
| $22.9M | 0.03% |
273,317
+9,719
| +4% | +$664K |
|
622
Clean Harbors
CLH
$16.7B
| $22.9M | 0.03% |
76,523
+46,102
| +152% | +$13.6M |
|
623
Factset
FDS
$10.7B
| $22.9M | 0.03% |
+99,341
| New | +$22.8M |
|
624
PUT
Pinduoduo
PDD
$126B
| $22.6M | 0.03% |
295,900
+88,100
| +42% | +$8.14M |
|
625
CALL
Coca-Cola
KO
$392B
| $22.5M | 0.03% |
276,600
+168,600
| +156% | +$13.3M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.